During the past decade, CCOP - Grand Rapids Clinical Oncology Program conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CCOP - Grand Rapids Clinical Oncology Program" #1 sponsor was "SWOG Cancer Research Network" with 33 trials, followed by "Eastern Cooperative Oncology Group" with 4 trials sponsored, "NSABP Foundation Inc" with 4 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored and "Children's Oncology Group" with 3 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CCOP - Grand Rapids Clinical Oncology Program" #1 collaborator was "National Cancer Institute (NCI)" with 46 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "Eastern Cooperative Oncology Group" with 3 trials as a collaborator and "NCIC Clinical Trials Group" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "CCOP - Grand Rapids Clinical Oncology Program" are "Lymphoma" (9 trials), "Lung Cancer" (8 trials), "Breast Cancer" (6 trials), "Leukemia" (5 trials) and "Colorectal Cancer" (3 trials). Many other conditions were trialed in "CCOP - Grand Rapids Clinical Oncology Program" in a lesser frequency.

Most popular intervention types in "CCOP - Grand Rapids Clinical Oncology Program" are "Drug" (44 trials), "Biological" (10 trials), "Radiation" (9 trials), "Procedure" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (11 trials), "doxorubicin hydrochloride" (8 trials), "cisplatin" (7 trials), "etoposide" (7 trials) and "paclitaxel" (7 trials). Other intervention names were less common.

The vast majority of trials in "CCOP - Grand Rapids Clinical Oncology Program" are 38 trials for "All" genders and 10 trials for "Female" genders.

Currently, there are NaN active trials in "CCOP - Grand Rapids Clinical Oncology Program". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 40 completed trials in CCOP - Grand Rapids Clinical Oncology Program, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in CCOP - Grand Rapids Clinical Oncology Program, 1 "Phase 1" clinical trials were conducted, 30 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".